Rapid Response Device Assesses Head Trauma Patients
By HospiMedica International staff writers Posted on 09 Dec 2014 |

Image: The BrainScope Ahead 100 system (Photo courtesy of Brainscope).
A noninvasive, handheld system uses an in situ electroencephalograph (EEG) to provide an interpretation of the structural condition of the patient’s brain after head injury.
The BrainScope Ahead 100 utilizes product miniaturization and advanced signal processing methods to provide an objective assessment and categorization of brain electrical activity associated with brain injury, identifying patterns consistent with a traumatically induced structural brain injury and clinical manifestations of functional traumatic brain injury (TBI). It is indicated for use as an adjunct to standard clinical practice for evaluation of patients who sustained a closed head injury within 24 hours, between the ages of 18–80 years, and who are being considered for a head computerized tomography (CT) scan.
The system consists of three main components: a hand-held device that includes software and algorithms for EEG acquisition, analysis, and patient stratification; a disposable electrode headset; and a web-based capability for centralized storage and review of patient data. The application of advanced mathematics and miniaturized hardware is designed to bridge the limitations of traditional EEG and provide tools for an initial assessment and adjunctive assessment across the brain care path. The Ahead 100 is a product of BrainScope (Bethesda, MD, USA), and has been approved by the US Food and Drug Administration (FDA).
“Over the last two years, we have focused on improving this technology, including adapting it for use on ubiquitous hardware platforms such as smartphones and tablets, and by benefitting from machine learning and proprietary algorithm classification techniques from increased data derived from our numerous clinical studies,” said Michael Singer, president and CEO of BrainScope. “We will direct all of our commercialization efforts for the Ahead product family using these hardware platforms both for assessment of structural brain injury in urgent care settings, and for assessment of concussion on the battlefield and the sports field.”
“Using sophisticated classification algorithm methods we sought neurophysiological profiles or signatures of changes in brain electrical activity associated with traumatic structural brain injury,” said Leslie Prichep, MD, director of the quantitative neurophysiological brain research lab at the NYU School of Medicine (NY, USA), and consultant to BrainScope. “One of the most important findings was the extremely high performance of the Ahead 100 to identify the absence of structural brain injury after a patient has sustained a head injury. This provides important information to the clinician, contributing to a rule-out for one of the most prevalent concerns clinicians have with mildly presenting patients.”
Head injury is the leading cause of death and disability in people under 45 years of age in developed countries, mostly resulting from falls and road accidents. The primary injury is caused by an initial mechanical force, followed by a secondary injury which develops in the hours and days afterwards, which is largely responsible for patients' mental and physical disabilities.
Related Links:
BrainScope
The BrainScope Ahead 100 utilizes product miniaturization and advanced signal processing methods to provide an objective assessment and categorization of brain electrical activity associated with brain injury, identifying patterns consistent with a traumatically induced structural brain injury and clinical manifestations of functional traumatic brain injury (TBI). It is indicated for use as an adjunct to standard clinical practice for evaluation of patients who sustained a closed head injury within 24 hours, between the ages of 18–80 years, and who are being considered for a head computerized tomography (CT) scan.
The system consists of three main components: a hand-held device that includes software and algorithms for EEG acquisition, analysis, and patient stratification; a disposable electrode headset; and a web-based capability for centralized storage and review of patient data. The application of advanced mathematics and miniaturized hardware is designed to bridge the limitations of traditional EEG and provide tools for an initial assessment and adjunctive assessment across the brain care path. The Ahead 100 is a product of BrainScope (Bethesda, MD, USA), and has been approved by the US Food and Drug Administration (FDA).
“Over the last two years, we have focused on improving this technology, including adapting it for use on ubiquitous hardware platforms such as smartphones and tablets, and by benefitting from machine learning and proprietary algorithm classification techniques from increased data derived from our numerous clinical studies,” said Michael Singer, president and CEO of BrainScope. “We will direct all of our commercialization efforts for the Ahead product family using these hardware platforms both for assessment of structural brain injury in urgent care settings, and for assessment of concussion on the battlefield and the sports field.”
“Using sophisticated classification algorithm methods we sought neurophysiological profiles or signatures of changes in brain electrical activity associated with traumatic structural brain injury,” said Leslie Prichep, MD, director of the quantitative neurophysiological brain research lab at the NYU School of Medicine (NY, USA), and consultant to BrainScope. “One of the most important findings was the extremely high performance of the Ahead 100 to identify the absence of structural brain injury after a patient has sustained a head injury. This provides important information to the clinician, contributing to a rule-out for one of the most prevalent concerns clinicians have with mildly presenting patients.”
Head injury is the leading cause of death and disability in people under 45 years of age in developed countries, mostly resulting from falls and road accidents. The primary injury is caused by an initial mechanical force, followed by a secondary injury which develops in the hours and days afterwards, which is largely responsible for patients' mental and physical disabilities.
Related Links:
BrainScope
Latest Critical Care News
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
- Implantable Device to Redefine Continuous Glucose Monitoring
- Smart Microgel Could Repair and Replace Damaged Organs
- Smart Breath Tracker Wristband to Revolutionize Respiratory Care
- Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients
Channels
Surgical Techniques
view channel
First-Ever Technology Makes Blood Translucent During Surgery
No matter the discipline or scale, bleeding is a regular part of any surgery and can create several challenges. In operating room imaging, seeing through blood in real-time during a surgery has been a... Read more
Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
Smith+Nephew (Hull, UK;) has launched its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more